New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects.

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.

With a major restructuring underway, Japanese pharma giant Takeda is entering a defining period for its business. Having completed years of portfolio reshaping following its acquisition of Shire in ...

Hemophilia is a rare, genetic disorder in which the blood does not clot enough to make bleeding slow down or stop. This is because patients with hemophilia do not have the normal amount of clotting ...

California-based Cargo Therapeutics has had a rough year with its CAR-T cell therapy firicabtagene autoleucel being discontinued after patients experienced toxic side effects in the clinic. The ...

For people living with sickle cell disease, it means facing lifelong challenges marked by episodes of severe pain, fatigue, and frequent medical visits. This is because the inherited blood disorder, ...

The life science sector brought about €29.7 billion ($34.41 billion) and €8.9 billion ($10.31 billion) in gross value added in 2024, according to a report by the Portuguese Trade & Investment Agency.